92 related articles for article (PubMed ID: 9454807)
21. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
Besecke LM; Wolfe AM; Pierce ME; Takahashi JS; Levine JE
Endocrinology; 1994 Oct; 135(4):1621-7. PubMed ID: 7925125
[TBL] [Abstract][Full Text] [Related]
22. Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization.
Voisin T; Goumain M; Lorinet AM; Maoret JJ; Laburthe M
J Pharmacol Exp Ther; 2000 Feb; 292(2):638-46. PubMed ID: 10640301
[TBL] [Abstract][Full Text] [Related]
23. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
26. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
Rimland JM; Seward EP; Humbert Y; Ratti E; Trist DG; North RA
Mol Pharmacol; 1996 Mar; 49(3):387-90. PubMed ID: 8643076
[TBL] [Abstract][Full Text] [Related]
27. Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons.
Abdulla FA; Smith PA
Neuroscience; 1999 Mar; 89(1):43-60. PubMed ID: 10051216
[TBL] [Abstract][Full Text] [Related]
28. Y2 receptor expression and inhibition of voltage-dependent Ca2+ influx into rod bipolar cell terminals.
D'Angelo I; Brecha NC
Neuroscience; 2004; 125(4):1039-49. PubMed ID: 15120863
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Fisher TA; Ji H
Regul Pept; 1998 Sep; 75-76():231-8. PubMed ID: 9802414
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y receptors involved in calcium channel regulation in PC12 cells.
McCullough LA; Egan TM; Westfall TC
Regul Pept; 1998 Sep; 75-76():101-7. PubMed ID: 9802399
[TBL] [Abstract][Full Text] [Related]
31. Agonists for neuropeptide Y receptor subtypes NPY-1 and NPY-2 have opposite actions on rat nodose neuron calcium currents.
Wiley JW; Gross RA; MacDonald RL
J Neurophysiol; 1993 Jul; 70(1):324-30. PubMed ID: 8395583
[TBL] [Abstract][Full Text] [Related]
32. Involvement of G-protein alpha il subunits in activation of G-protein gated inward rectifying K+ channels (GIRK1) by human NPY1 receptors.
Brown NA; McAllister G; Weinberg D; Milligan G; Seabrook GR
Br J Pharmacol; 1995 Nov; 116(5):2346-8. PubMed ID: 8581266
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y contributes to innervation-dependent increase in I(Ca, L) via ventricular Y2 receptors.
Protas L; Robinson RB
Am J Physiol; 1999 Sep; 277(3):H940-6. PubMed ID: 10484414
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y system in the retina: From localization to function.
Santos-Carvalho A; Ambrósio AF; Cavadas C
Prog Retin Eye Res; 2015 Jul; 47():19-37. PubMed ID: 25797468
[TBL] [Abstract][Full Text] [Related]
35. Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function.
Jacques D; Sader S; Perreault C; Abdel-Samad D; Provost C
Can J Physiol Pharmacol; 2006 Jul; 84(7):695-705. PubMed ID: 16998533
[TBL] [Abstract][Full Text] [Related]
36. Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC-12 cells.
Chen X; Westfall TC
Am J Physiol; 1994 Mar; 266(3 Pt 1):C784-93. PubMed ID: 8166242
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y activates inwardly-rectifying K(+)-channels in C-cells of amphibian sympathetic ganglia.
Zidichouski JA; Chen H; Smith PA
Neurosci Lett; 1990 Sep; 117(1-2):123-8. PubMed ID: 2290607
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes.
Millar BC; Weis T; Piper HM; Weber M; Borchard U; McDermott BJ; Balasubramaniam A
Am J Physiol; 1991 Dec; 261(6 Pt 2):H1727-33. PubMed ID: 1661086
[TBL] [Abstract][Full Text] [Related]
39. Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.
Gicquiaux H; Lecat S; Gaire M; Dieterlen A; Mély Y; Takeda K; Bucher B; Galzi JL
J Biol Chem; 2002 Feb; 277(8):6645-55. PubMed ID: 11741903
[TBL] [Abstract][Full Text] [Related]
40. Low potency inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by [Ala31]NPY, an L-alanine substituted analogue of neuropeptide Y.
McDonald RL; Beck-Sickinger AG; Rist B; Vaughan PF; Peers C
Neurosci Lett; 1995 May; 190(3):179-82. PubMed ID: 7637888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
